![Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline | JCO Global Oncology Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline | JCO Global Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jgo/2019/jgo.2019.5/jgo.18.00214/20190326/images/large/jgo.18.00214t9.jpeg)
Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline | JCO Global Oncology
![The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 - The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -](https://www.thelancet.com/cms/attachment/5345df8f-353b-4fd3-bb34-8d6aa0db4c83/gr1.jpg)
The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -
![Cancers | Free Full-Text | Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies Cancers | Free Full-Text | Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies](https://www.mdpi.com/cancers/cancers-14-01732/article_deploy/html/images/cancers-14-01732-g001.png)
Cancers | Free Full-Text | Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies
![Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/45a4e999-c20d-4e3d-b00f-b8b47fe296f2/gr1.jpg)
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Gastroenterology & Hepatology
![Early-onset colorectal cancer: initial clues and current views | Nature Reviews Gastroenterology & Hepatology Early-onset colorectal cancer: initial clues and current views | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-019-0253-4/MediaObjects/41575_2019_253_Fig1_HTML.png)
Early-onset colorectal cancer: initial clues and current views | Nature Reviews Gastroenterology & Hepatology
![Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies | Nature Reviews Gastroenterology & Hepatology Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-019-0189-8/MediaObjects/41575_2019_189_Fig1_HTML.png)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies | Nature Reviews Gastroenterology & Hepatology
![Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer: Trends in Microbiology Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer: Trends in Microbiology](https://www.cell.com/cms/asset/bf8af85e-414b-4c0d-8651-a588449266a3/gr1.jpg)
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer: Trends in Microbiology
![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics](https://www.cell.com/cms/asset/e00a3f4f-dad6-442c-89ac-c4c86fc0c40e/fx1.jpg)